JPRN-UMIN000005409已完成未知
Effects of Olmesartan Medoxomil Angiotensin Type 1 (AT1) Receptor Blocker 1 in Selected Patients with Nonalcoholic Steatohepatitis (NASH): Pilot Study - Effects of Olmesartan Medoxomil Angiotensin Type 1 (AT1) Receptor Blocker 1 in Selected Patients with Nonalcoholic Steatohepatitis (NASH): Pilot Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Mean arterial pressure is less than 60 mmHg. (2)ARB intolerance. (3)Current treatment with ARB, angiotensin-converting enzyme inhibitors, or beta blockers. (4)Hypertrophic cardiomyopathy or renal arterial stenosis. (5)Serum creatinine is more than 1.6 mg/dL. (6)Hyperkalemia defined as plasma potassium more than 5.5 meq/L. (7)Hepatocellular carcinoma. (8)Portal venous tumor thrombosis.
研究者
相似试验
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Vascular Markers in Hypertensive Patients with Metabolic Syndrome - VAMOSEUCTR2007-003130-41-DEDAIICHI-SANKYO EUROPE GmbH
终止
2 期
Telmisartan in the management of abdominal aortic aneurysmAbdominal Aortic AneurysmACTRN12611000931976James Cook University208
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-BEDAIICHI SANKYO EUROPE GmbH264
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-NLDAIICHI SANKYO EUROPE GmbH350
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1 Level: LLT Classification code 10052066 Term: Metabolic syndromeMedDRA version: 9.1 Level: LLT Classification code 10020772 Term: HypertensionEUCTR2007-003131-23-GBDAIICHI SANKYO EUROPE GmbH350